Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Morningside Healthcare Ltd., Unit C, Harcourt Way, Leicester, LE19 1WP, United Kingdom
Cimizt 150 microgram/30 microgram Tablets.
Pharmaceutical Form |
---|
Tablet. Each tablet is round, white to off-white, 5.00 mm, uncoated, biconvex, debossed with ‘142’ on one side and other side plain. |
Each tablet contains 150 micrograms desogestrel and 30 micrograms ethinylestradiol.
Excipients: 1 uncoated tablet contains 58 mg of lactose anhydrous
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
17 alpha-Ethinylestradiol |
Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
|
Desogestrel |
Desogestrel is a progestogen. Like other progestogen-only pills, desogestrel is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of desogestrel is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus. |
List of Excipients |
---|
all-rac-alpha-tocopherol |
Clear transparent PVC/PVdC- Aluminium blister of 21 tablets per calender blister strip available in packs containing 1x21, 3x21 or 6x21 tablets. Each blister is packed in trilaminated pouch.
Clear transparent PVC/PVdC- Aluminium blister of 21 tablets per calender blister strip available in packs containing 1x21, 3x21 or 6x21 tablets. Each blister is packed in trilaminated pouch along with 2g molecular sieve.
Not all pack sizes may be marketed.
Morningside Healthcare Ltd., Unit C, Harcourt Way, Leicester, LE19 1WP, United Kingdom
PL 20117/0231
28/05/2012
Drug | Countries | |
---|---|---|
CIMIZT | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.